Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
US Stock MarketDetailed Quotes
RFL Rafael Holdings
- 1.950
- +0.150+8.33%
Close Dec 20 16:00 ET
- 1.950
- 0.0000.00%
Post 20:01 ET
48.11MMarket Cap-1.17P/E (TTM)
1.950High1.720Low74.21KVolume1.750Open1.800Pre Close140.82KTurnover0.39%Turnover RatioLossP/E (Static)24.67MShares2.50052wk High0.65P/B36.92MFloat Cap1.29052wk Low--Dividend TTM18.93MShs Float66.440Historical High--Div YieldTTM12.78%Amplitude1.290Historical Low1.897Avg Price1Lot Size
About Rafael Holdings Company
Rafael Holdings, Inc. owns an interest in clinical and early-stage pharmaceutical companies. It operates through the Healthcare, Infusion Technology and Real Estate segments. The Healthcare segment relates to the activities of LipoMedix, Barer, Farber, and Rafael Medical Devices. The company was founded in 2017 and is headquartered in Newark, NJ.
Company Profile
SymbolRFL
Company NameRafael Holdings
Listing DateMar 27, 2018
Founded2017
CEOMr. William Conkling
MarketNYSE
Employees31
Fiscal Year Ends07-31
Address520 Broad Street
CityNewark
ProvinceNew Jersey
CountryUnited States of America
Zip Code07102
Phone1-212-658-1450
Company Executives
- Name
- Position
- Salary
- William Conkling
- President and Chief Executive Officer
- 859.30K
- John M. Goldberg, M.D.
- Chief Medical Officer
- 758.06K
- David Polinsky
- Chief Financial Officer and Principal Accounting Officer
- --
- Howard S. Jonas
- Chairman of the Board and Executive Chairman
- 540.33K
- Susan Y. Bernstein
- Director
- --
- Dr. Mark N. Stein, M.D.
- Director
- --
- Stephen M. Greenberg
- Lead Independent Director
- 75.06K
- Dr. Michael J. Weiss, M.D.
- Independent Director
- 75.06K